Meta-analysis shows extended therapy improves response of patients with chronic hepatitis C virus genotype 1 infection.
| Data(s) |
2010
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_D87C733F8DEA isbn:1542-7714[electronic], 1542-3565[linking] pmid:20601130 doi:10.1016/j.cgh.2010.06.019 isiid:000283042500015 |
| Idioma(s) |
en |
| Fonte |
Clinical Gastroenterology and Hepatology, vol. 8, no. 10, pp. 884-890 |
| Palavras-Chave | #Antiviral Agents/administration & dosage; Drug Therapy, Combination/methods; Genotype; Hepacivirus/classification; Hepacivirus/genetics; Hepatitis C, Chronic/drug therapy; Humans; Interferon Alfa-2a/administration & dosage; Interferon Alfa-2b/administration & dosage; Polyethylene Glycols/administration & dosage; RNA, Viral/blood; Randomized Controlled Trials as Topic; Ribavirin/administration & dosage; Time Factors; Treatment Outcome; Viral Load |
| Tipo |
info:eu-repo/semantics/article article |
